使用CD36向脂质核探测器对动脉样硬化斑块进行高级检测和治疗监测
Tingting Gao1, Siqi Gao1, Maolin Qiao1
1The Second Clinical Medical College, Shanxi Medical University, Taiyuan 030000, China.
Pharmaceutics
|April 26, 2025
概括
一个新的光探针CD36pep-ICG,通过结合脂质死核,有效地准并检测易受动脉样硬化斑块. 这种分子成像工具有助于早期诊断和监测心血管疾病的治疗反应.
科学领域:
- 生物医学成像技术 生物医学成像技术
- 分子探头分子探头
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化是全球死亡的主要原因,它涉及动脉中的斑块积累.
- 脆弱的动脉样硬化斑块可能会破裂,导致血栓形成和心血管事件.
- 早期发现高风险斑块对于预防不良结果至关重要.
研究的目的:
- 开发一种用于动脉样硬化斑块的新型分子成像探针.
- 设计一个光探针,准脂质死核,用于高风险斑块检测.
- 使动脉样硬化的早期诊断和干预成为可能.
主要方法:
- 通过生物信息学分析和免疫光检测,在人类的状腺斑块中检测到CD36的表达.
- 通过Fmoc固相合成合成CD36pep-ICG探针进行合成.
- 评估探头特性,体外成像性能,以及体外动物模型中的准.
主要成果:
- 在斑块核中,CD36表达显著更高.
- 成功合成了具有出色光特性的CD36pep-ICG探针.
- FLI成像证实了探针在动脉样硬化斑块中的选择性积累,从而能够精确检测和监测治疗疗效.
结论:
- CD36pep-ICG探针是一种有效的分子成像工具,用于识别脆弱的动脉样硬化斑块.
- 这种探测器为心血管疾病的早期诊断和干预提供了一种新的方法.
- 该探测器显示了监测药物疗效的潜力,促进了动脉样硬化的精密治疗.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
973
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655


